PONTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.619
EU - Europa 6.718
AS - Asia 1.008
SA - Sud America 33
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 9
OC - Oceania 6
Totale 22.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.335
GB - Regno Unito 2.818
IT - Italia 1.329
SE - Svezia 799
DE - Germania 571
UA - Ucraina 426
CN - Cina 370
TR - Turchia 304
FI - Finlandia 239
CA - Canada 215
BG - Bulgaria 159
FR - Francia 158
HK - Hong Kong 147
MX - Messico 66
RU - Federazione Russa 48
VN - Vietnam 45
BE - Belgio 39
SG - Singapore 37
IE - Irlanda 34
IN - India 33
NL - Olanda 24
JP - Giappone 18
BR - Brasile 16
MY - Malesia 16
RO - Romania 13
KR - Corea 11
EU - Europa 10
CH - Svizzera 9
ES - Italia 9
CL - Cile 8
IR - Iran 8
LU - Lussemburgo 8
PT - Portogallo 7
AU - Australia 5
NO - Norvegia 5
PE - Perù 5
LB - Libano 4
NG - Nigeria 4
PL - Polonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
BD - Bangladesh 3
SI - Slovenia 3
AR - Argentina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HU - Ungheria 2
IL - Israele 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SD - Sudan 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
SM - San Marino 1
VE - Venezuela 1
Totale 22.406
Salva come PNG Salva come JPEG
Città #
Fairfield 2.475
Southend 2.461
Woodbridge 1.546
Houston 1.134
Ashburn 1.074
Seattle 944
Chandler 902
Jacksonville 820
Wilmington 798
Cambridge 794
Dearborn 783
Ann Arbor 648
Nyköping 532
Modena 270
Princeton 198
San Diego 194
Ottawa 192
Izmir 188
Sofia 159
Eugene 154
Hong Kong 144
Beijing 136
Helsinki 106
London 89
Bremen 80
Milan 61
Rome 59
Redwood City 54
Grafing 51
Dong Ket 44
New York 42
Norwalk 34
Des Moines 33
Fremont 33
Dublin 31
Boardman 30
Brussels 30
Chiswick 23
Hefei 22
Hounslow 22
Nanjing 22
San Mateo 21
Bologna 20
Buffalo 17
Falls Church 17
Kunming 17
Phoenix 15
Shanghai 15
Tulare 14
Parma 13
Guangzhou 12
Genova 11
Jinan 11
Padova 11
Saint Petersburg 11
Verona 11
Auburn Hills 10
Augusta 10
Mumbai 10
Napoli 10
Palermo 10
Toronto 10
Indiana 8
Philadelphia 8
Prescot 8
Segrate 8
Turin 8
Waanrode 8
Cagliari 7
Chicago 7
Chieti 7
Nanchang 7
Naples 7
Castelnuovo Rangone 6
Catania 6
Ceranova 6
Frankfurt am Main 6
Fuzhou 6
Hanover 6
Leawood 6
Mountain View 6
Salerno 6
Trieste 6
Bari 5
Dallas 5
Florence 5
Grosseto 5
Kemerovo 5
Lima 5
Los Angeles 5
Niterói 5
Pescara 5
Seoul 5
Shenyang 5
Xian 5
Amsterdam 4
Atlanta 4
Brescia 4
Bucharest 4
Changsha 4
Totale 17.911
Salva come PNG Salva come JPEG
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 424
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 340
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 259
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 243
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 243
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 235
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 231
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 230
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 222
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 221
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 218
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 216
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 215
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. 214
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 213
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 212
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 212
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 211
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 211
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 211
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 209
Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas 205
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 201
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 200
Confocal microscopy characterization of BRAFV600E mutated melanomas 199
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 197
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 197
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 192
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 191
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 191
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. 190
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 190
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 186
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 185
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 185
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 185
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 185
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 185
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 184
Desmoplastic melanoma: a challenge for the oncologist 184
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 184
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 183
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 181
Aetiology of colorectal cancer and relevance of monogenic inheritance. 180
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 180
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 179
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 179
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 179
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 178
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 178
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 178
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 176
Stem cell properties in cell cultures from different stage of melanoma progression. 174
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 172
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 170
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 170
Microsatellite instability and colorectal cancer prognosis. 169
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 169
Clinical utility gene card for: Gorlin syndrome - update 2013. 168
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 165
Biomarkers associated with COVID-19 disease progression 165
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 163
The dermoscopic variability of pigment network in melanoma in situ. 162
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 162
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 161
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 160
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 158
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 158
Giuseppe Moscati (1880-1927): a holistic approach to medicine 158
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. 157
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 156
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 152
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report 152
Variegated Dermoscopy of in situ Melanoma. 150
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 149
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 149
Diagnosis of BCC by multiphoton laser tomography. 147
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 147
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 147
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 147
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 146
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 144
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 144
High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. 144
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 143
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 143
Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopy 143
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 143
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 142
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 142
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 141
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 140
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 137
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 135
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 134
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 133
Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications 132
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 128
Microsatellite Instability and Mismatch Repair protein expression in Sebaceous tumors, Keratocanthoma and Basal Cell Carcinomas with sebaceous differentiation in Muir-Torre Syndrome. 128
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 127
Totale 18.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.129 0 0 0 0 0 114 240 26 231 258 624 636
2019/20206.192 484 219 186 328 656 887 1.028 811 798 215 398 182
2020/20214.986 604 165 478 416 652 335 425 563 222 523 275 328
2021/20223.192 221 406 328 179 72 175 171 176 348 234 544 338
2022/20232.756 351 338 203 231 323 373 69 254 318 53 137 106
2023/2024907 89 90 137 174 393 24 0 0 0 0 0 0
Totale 22.800